organization · Reporting owner
Fifth Cinven Fund (No. 3) Limited Partnership
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Medpace Holdings, Inc.
Report date June 21, 2017 · Filed June 22, 2017
Jointly reported with Fifth Cinven Fund (No. 1) Limited Partnership, Fifth Cinven Fund (No. 2) Limited Partnership, Fifth Cinven Fund (No. 4) Limited Partnership, Fifth Cinven Fund (No. 5) Limited Partnership, Fifth Cinven Fund (No. 6) Limited Partnership, Fifth Cinven Fund Co-Investment Partnership, Cinven Manco S.A.R.L., Fifth Cinven Fund FCP-SIF
Section 16 reporting ended · disclosed 2017-06-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2017-06-21 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2017-06-21 · Other · Disposed 22,999,997 · Balance 0 F1: Represents a transfer by the Cinven Shareholders (as defined below) to Medpace Limited Partnership in exchange for limited partnership interests in Medpace Limited Partnership in connection with the execution of a margin loan agreement by Medpace Limited Partnership. F2: Prior to the transactions reported herein, included 3,641,240 shares held by Fifth Cinven Fund (No. 1) Limited Partnership ("LP1"), 3,229,699 shares held by Fifth Cinven Fund (No. 2) Limited Partnership ("LP2"), 3,889,854 shares held by Fifth Cinven Fund (No. 3) Limited Partnership ("LP3"), 3,379,103 shares held by Fifth Cinven Fund (No. 4) Limited Partnership ("LP4"), 1,403,731 shares held by Fifth Cinven Fund (No. 5) Limited Partnership ("LP5"), 3,284,802 shares held by Fifth Cinven Fund (No. 6) Limited Partnership ("LP6" and, together with LP1, LP2, LP3, LP4 and LP5, the "Limited Partnerships"), 3,758,169 shares held by Fifth Cinven Fund FCP-SIF ("FCP"), which is managed and controlled by Cinven Manco S.A.R.L. ("Manco"), and 413,399 shares held by Fifth Cinven Fund Co-Investment Partnership ("CIP" and, together with the Limited Partnerships and FCP, the "Cinven Shareholders"). F3: Each of the Limited Partnerships is managed and controlled by Cinven Capital Management (V) Limited Partnership Incorporated ("GPLP"), their Managing General Partner. Cinven Capital Management (V) General Partner Limited ("Cinven MGP") is the Managing General Partner of GPLP. FCP is managed and controlled by Cinven Manco S.A.R.L. ("Manco"). Cinven MGP also exercises control over the shares held by each of FCP and CIP, which are subject to contractual commitments that each invest and divest side-by-side with the Limited Partnerships. Voting and investment determinations with respect to the shares held by the Cinven Shareholders are made by the majority vote of the board of directors of Cinven MGP, comprised of Brian Linden, Hayley Tanguy, John Boothman, Robin Hall, Rupert Dorey and William Scott. Each such director disclaims beneficial ownership of such shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a transfer by the Cinven Shareholders (as defined below) to Medpace Limited Partnership in exchange for limited partnership interests in Medpace Limited Partnership in connection with the execution of a margin loan agreement by Medpace Limited Partnership.
F2: Prior to the transactions reported herein, included 3,641,240 shares held by Fifth Cinven Fund (No. 1) Limited Partnership ("LP1"), 3,229,699 shares held by Fifth Cinven Fund (No. 2) Limited Partnership ("LP2"), 3,889,854 shares held by Fifth Cinven Fund (No. 3) Limited Partnership ("LP3"), 3,379,103 shares held by Fifth Cinven Fund (No. 4) Limited Partnership ("LP4"), 1,403,731 shares held by Fifth Cinven Fund (No. 5) Limited Partnership ("LP5"), 3,284,802 shares held by Fifth Cinven Fund (No. 6) Limited Partnership ("LP6" and, together with LP1, LP2, LP3, LP4 and LP5, the "Limited Partnerships"), 3,758,169 shares held by Fifth Cinven Fund FCP-SIF ("FCP"), which is managed and controlled by Cinven Manco S.A.R.L. ("Manco"), and 413,399 shares held by Fifth Cinven Fund Co-Investment Partnership ("CIP" and, together with the Limited Partnerships and FCP, the "Cinven Shareholders").
F3: Each of the Limited Partnerships is managed and controlled by Cinven Capital Management (V) Limited Partnership Incorporated ("GPLP"), their Managing General Partner. Cinven Capital Management (V) General Partner Limited ("Cinven MGP") is the Managing General Partner of GPLP. FCP is managed and controlled by Cinven Manco S.A.R.L. ("Manco"). Cinven MGP also exercises control over the shares held by each of FCP and CIP, which are subject to contractual commitments that each invest and divest side-by-side with the Limited Partnerships. Voting and investment determinations with respect to the shares held by the Cinven Shareholders are made by the majority vote of the board of directors of Cinven MGP, comprised of Brian Linden, Hayley Tanguy, John Boothman, Robin Hall, Rupert Dorey and William Scott. Each such director disclaims beneficial ownership of such shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 21, 2017 Filed Jun 22, 2017 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | OtherCommon Stock | 22,999,997 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-016948 · doc4.xml · nonDerivative · entry 1 Fifth Cinven Fund (No. 1) Limited Partnership · CIK 0001538517 · 10% owner Fifth Cinven Fund (No. 2) Limited Partnership · CIK 0001548370 · 10% owner Fifth Cinven Fund (No. 3) Limited Partnership · CIK 0001548369 · 10% owner Fifth Cinven Fund (No. 4) Limited Partnership · CIK 0001548368 · 10% owner Fifth Cinven Fund (No. 5) Limited Partnership · CIK 0001560588 · 10% owner Fifth Cinven Fund (No. 6) Limited Partnership · CIK 0001573041 · 10% owner Fifth Cinven Fund Co-Investment Partnership · CIK 0001677857 · 10% owner Cinven Manco S.A.R.L. · CIK 0001677872 · 10% owner Fifth Cinven Fund FCP-SIF · CIK 0001677859 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · kind: Represents a transfer by the Cinven Shareholders (as defined below) to Medpace Limited Partnership in exchange for limited partnership interests in Medpace Limited Partnership in connection with the execution of a margin loan agreement by Medpace Limited Partnership. F2 · ownership.nature: Prior to the transactions reported herein, included 3,641,240 shares held by Fifth Cinven Fund (No. 1) Limited Partnership ("LP1"), 3,229,699 shares held by Fifth Cinven Fund (No. 2) Limited Partnership ("LP2"), 3,889,854 shares held by Fifth Cinven Fund (No. 3) Limited Partnership ("LP3"), 3,379,103 shares held by Fifth Cinven Fund (No. 4) Limited Partnership ("LP4"), 1,403,731 shares held by Fifth Cinven Fund (No. 5) Limited Partnership ("LP5"), 3,284,802 shares held by Fifth Cinven Fund (No. 6) Limited Partnership ("LP6" and, together with LP1, LP2, LP3, LP4 and LP5, the "Limited Partnerships"), 3,758,169 shares held by Fifth Cinven Fund FCP-SIF ("FCP"), which is managed and controlled by Cinven Manco S.A.R.L. ("Manco"), and 413,399 shares held by Fifth Cinven Fund Co-Investment Partnership ("CIP" and, together with the Limited Partnerships and FCP, the "Cinven Shareholders"). F3 · ownership.nature: Each of the Limited Partnerships is managed and controlled by Cinven Capital Management (V) Limited Partnership Incorporated ("GPLP"), their Managing General Partner. Cinven Capital Management (V) General Partner Limited ("Cinven MGP") is the Managing General Partner of GPLP. FCP is managed and controlled by Cinven Manco S.A.R.L. ("Manco"). Cinven MGP also exercises control over the shares held by each of FCP and CIP, which are subject to contractual commitments that each invest and divest side-by-side with the Limited Partnerships. Voting and investment determinations with respect to the shares held by the Cinven Shareholders are made by the majority vote of the board of directors of Cinven MGP, comprised of Brian Linden, Hayley Tanguy, John Boothman, Robin Hall, Rupert Dorey and William Scott. Each such director disclaims beneficial ownership of such shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.